Our study revealed that the use of various classes of statins that are known to be competitive inhibitors of HMG-CoA reductase, the rate-limiting enzyme for cholesterol synthesis, reduced SARS-CoV-2 entry into and infection of the cell lines. Here, HMGCR is linked to infection.